The global surgical stapling devices market size was valued at USD 4.27 billion in 2018. It is projected to expand at a CAGR of 8.23% over the forecast period. Growing preference for staples over sutures has been one of the primary growth stimulant for the market. With technological advancements, several market players are commercializing staplers used for endoscopic surgeries. These devices find applications across various branches of medicine, such as gynaecology, thoracic, and gastrointestinal-related surgeries as well as tissue & wound management procedures.
The demand for surgical stapling devices is poised to increase owing to rise in bariatric procedures and implementation of advanced technologies to perform endoscopic procedures. In addition, introduction of powered surgical devices and soaring need for tissue & wound management is likely to further drive the market.
Initially, sutures were widely used for wound closure surgeries. However, introduction of staplers has gradually outpaced the suture market due to several advantages. Apart from being a tedious process, sutured sites may exhibit wound leakage and separation, whereas surgical staplers offer better speed, accuracy, and efficient wound closure.
With increasing technological advancements, several market players are commercializing staplers used for endoscopic surgeries. These devices find application across various branches of medicine, such as gynaecology, thoracic, gastrointestinal-related surgeries, and tissue & wound management procedures.
Moreover, in developing countries, such as India and China, surgical staplers are widely employed for bariatric surgeries. Covidien plc and Ethicon Endo-Surgery, Inc. offering titanium stomach staples, reported that obesity-related surgeries in India have doubled since 2013 and hence, the number of bariatric procedures has increased in the country.
Conventionally, manual surgical staplers were used along with scalpels, forceps, and scissors. With surging demand and increasing frequency of surgeries, powered stapling devices are expected to post a higher CAGR over the forecast period. These powered devices help doctors address the problem of fatigue that may be caused due to high procedure volume in hospital emergency wards.
Moreover, laparoscopic surgeries require accuracy while execution within restricted anatomical spaces and are typically labour-intensive. The prime advantage offered by powered stapling devices includes ease of wound closure without requirement of manual firing force.
Introduction of novel technologies, such as biowelding and cold plasma, used for sealing wounds without scars or stitches, is estimated to stir up the demand for electrosurgical devices. They are anticipated to emerge as an alternative to sealants, staples, and sutures. They are approved in Europe and is used in skin grafting.
By type, the surgical stapling devices market has been bifurcated into disposable and reusable. Medical grade plastic is the material used in disposable devices while reusable devices are made from stainless steel used for biomedical application. Both types possess disposable cartridges.
The disposable segment is anticipated to register a noteworthy CAGR over the forecast period as a result of heightened concerns regarding communicable infections. The Centers for Disease Control and Prevention (CDC) promotes the use of disposable devices and provides protocols to prevent spread of pathogens. Regulatory authorities such as the U.S. Food and Drug Administration (FDA) have also stated some measures to ensure that set protocols for sterilization of medical devices are strictly followed in order to avoid infections.
Lifestyle changes have led to rise in people suffering from obesity, especially in developed countries such as the U.S. This has resulted in increase in demand for bariatric or weight loss procedures, ultimately increasing application of stapling equipment. For instance, approximately 113,000 bariatric surgeries are performed every year in the U.S. alone. The trend of opting for bariatric surgery is gaining grounds in developing countries too. India is one of the fastest growing markets for bariatric procedures, with a supply of 10,000 staplers every year.
Based on end use, the market has been divided into hospitals and ambulatory centers. The hospitals segment was identified as the largest end-use segment in 2018 whereas the ambulatory centres segment is projected to exhibit the highest CAGR over the forecast period. The steady growth of the ambulatory centers segment can be attributed to factors such as scarce economic resources and shortage of hospital beds, especially in underdeveloped and developing economies.
A major trend in hospitals suggest a shift towards clinical efficiency models, which include introduction of robotic technology in surgery. Robotic surgeries improve the outcome of minimally invasive surgeries. The hospital segment is poised to retain its dominance over the forecast period owing to favorable reimbursement scenario for bariatric surgeries. This is available solely for inpatients and hospital outpatients, while ambulatory centers are not covered under this code.
In 2018, North America held the largest share in the market owing to the use of advanced technologies and non-invasive methods in increasing number of total surgeries performed. Other reasons for sizeable market share are the highest obesity rate in this region, local presence of global players, and FDA approval for non-invasive surgeries. With recent developments in minimally invasive surgeries, special devices are designed for laparoscopic and thoracoscopic surgeries, which includes use of surgical stapling devices. It has become responsibility of surgeons to acquire prerequisite knowledge of stapling devices.
Asia Pacific is likely to exhibit the highest CAGR of 9.07% during the forecast period due to presence of a large patient pool in economies such as India, China, and Japan. In 2011, surgical staplers were categorized under “drugs” and were regulated under the Drugs and Cosmetics Act in India because of increasing demand and use. Implementation of this act rendered strict regulations for manufacturing and distribution of surgical staplers.
With increasing conduct of surgical procedures, coupled with rising healthcare expenditure, and rising awareness regarding the use of them, the demand for stapling is expected to witness lucrative growth. Key players in the market are also investing in this region to expand their footprints. Initiatives such as those taken by Johnson & Johnson Medical, India, to train 8,000 doctors in advanced surgical products, including non-invasive surgical staples, are estimated to propel the market in the region.
Some key industry contributors are Covidien plc; Ethicon Endo-Surgery, Inc.; Cardica, Inc.; Zimmer Holdings, Inc.; Stryker Corporation; Smith & Nephew plc; Conmed Corporation; and CareFusion Corporation.
Ethicon, Inc.; Covidien plc (Medtronic plc); and Stryker Corporation were the most attractive participants in the market in 2018. In November 2018, Ethicon launched its Bariatric Revision Surgical Solutions, a range of products that include ECHELON FLEX GST System, HARMONIC HD 1000i Shears energy device, SURGICEL SNoW Absorbable Hemostat for haemostasis & tissue adherence, and STRATAFIX Knotless Tissue Control devices for suturing.
In March 2017, Ethicon announced results of retrospective studies conducted to compare two products, viz. Ethicon’s ECHELON FLEX Powered Staplers and Medtronic’s ENDO GIA Manual Staplers. The results were published in The Journal of Medical Economics and showed that Ethicon’s product was associated with economic and clinical benefits and lower rate of bleeding complications. In February 2017, Medtronic launched its new stapling system, Signia Stapling System. This was the newest addition to the company’s minimally invasive system product portfolio.
Base year for estimation
Actual estimates/Historical data
2015 - 2017
2019 - 2026
Revenue in USD Million & CAGR from 2019 to 2026
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, France, Germany, U.K., Spain, Italy, Netherlands, Switzerland, Belgium, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Turkey, Saudi Arabia, Israel
Revenue forecast, competitive landscape, growth factors & trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of industry trends in each of the sub segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global surgical stapling devices market report based on product, type, end use, and region:
Product Outlook (Revenue, USD Million, 2015 - 2026)
Powered Surgical Stapling Device
Manual Surgical Stapling Device
Type Outlook (Revenue, USD Million, 2015 - 2026)
Disposable Surgical Stapling Device
Reusable Surgical Stapling Device
End Use Outlook (Revenue, USD Million, 2015 - 2026)
Regional Outlook (Revenue, USD Million, 2015 - 2026)
Middle East & Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.